Carteolol-d9 hydrochloride

• CAT Number: S000312
• CAS Number: 1346602-13-8
• Molecular Formula: C16H16D9ClN2O3
• Molecular Weight: 337.89
• Purity: ≥95%
• IUPAC Name: 5-[3-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochloride
• InChI: InChI=1S/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H/i1D3,2D3,3D3
• InChIKey: FYBXRCFPOTXTJF-KYRNGWDOSA-N
• SMILES: CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O.Cl

Carteolol-d9 hydrochloride（Cat No.:S000312） is a deuterated variant of carteolol hydrochloride, where nine hydrogen atoms are replaced with deuterium. This modification enhances its molecular stability, making it useful as an internal standard for analytical techniques such as mass spectrometry and NMR spectroscopy. Carteolol is a non-selective beta-blocker used primarily in the treatment of glaucoma to reduce intraocular pressure and also to manage hypertension. The deuterium in carteolol-d9 allows for more detailed studies of the drug’s pharmacokinetics, improving the understanding of its metabolic pathways and excretion processes.